Free press releases distribution network?

Agency / Source: Dentsu

Check Ads Availability|e-mail Article
This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit - Dentsu, Inc. announced that Dentsu Ventures Global Fund I (hereinafter
Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit

 

PRTODAY - Newswire & PRZOOM/ - Tokyo, Japan, 11/15/2017 - Dentsu, Inc. announced that Dentsu Ventures Global Fund I (hereinafter "Dentsu Ventures") has made an investment in Twist Bioscience Corporation - twistbioscience.com / Dentsu-V.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Marketing/Newswire/PR Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dentsu, Inc. (President & CEO: Toshihiro Yamamoto; Head Office: Tokyo; Capital: 74,609.81 million yen) announced today that Dentsu Ventures Global Fund I (hereinafter "Dentsu Ventures"), the Company's corporate venture capital fund, has made an investment in Twist Bioscience Corporation (Head Office: San Francisco; CEO: Emily LeProust (hereinafter,"Twist Bioscience"), a U.S. company providing high-throughput DNA synthesis for multiple industries.

Twist Bioscience (twistbioscience.com) has developed proprietary technologies that enable DNA synthesis to be performed in a highly efficient manner, more quickly and at lower cost than conventional production processes, and provides DNA in response to a variety of client needs. Rather than conventional plastic plates, Twist Bioscience synthesizes DNA on silicon plates it has developed in house. This approach achieves breakthrough increases in efficiency, speed and quality of DNA production, compared with conventional DNA synthesis processes. The company serves customers in an array of markets including drug discovery, new materials production, agriculture, academia and medical diagnosis. Going forward, the company plans to utilize its DNA synthesis technology to expand into the data storage business, leveraging its efforts in the drug discovery and development business.

Dentsu Ventures (dentsu-v.com) plans to support Twist Bioscience's partnership strategy for developing potential technologies utilized on a variety of fronts, from pharmaceutical production to biocomputing. By forming alliances with Dentsu Group clients and partner companies, Dentsu Ventures will support Twist Bioscience's innovative business development.

Profiles of Twist Bioscience and Dentsu Ventures are provided below.
Profile of Twist Bioscience
Company Name: Twist Bioscience Corporation
Location: San Francisco, California, U.S.A.
Representative: Emily LeProust (CEO)
Line of Business: Providing High-Throughput DNA Synthesis for Multiple Industries

Profile of Dentsu Ventures
Name: Dentsu Ventures Global Fund I
Total Fund Capital: 10.0 billion yen
Date of Establishment: April 2015
Period of Operation: Slated for 10-year period, through March 2025
Investment Regions: Global investments with a focus on the U.S., Europe Japan and Asia
Investment Stages: Balanced, wide-ranging investments with the focus on seed and early stage investments, but also including mid-stage and later-stage investments.
Investment Areas:
(1) Areas that can change the marketing and communication business in a broad sense
(2) New areas other than the above that have a high potential for innovation

Investment-related enquiries: Dentsu Ventures
E: info[.]dentsu-v.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Marketing/Newswire/PR Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Dentsu

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRTODAY - Newswire Distribution Service Visibility Checker

 

Distribution / Indexing: [+] [Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Marketing/Newswire/PR articles,
CATCH Visitors via Your Competitors Announcements!


Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRTODAY - Newswire Distribution Service and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Shusaku Kannan - Dentsu.co.jp 
+81 3-6216-8042 s.kannan[.]dentsu.co.jp
 
Newswire Today - PRZOOM disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.

Marketing/Newswire/PR via RSS
AddThis press release: Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the UnitAdd Marketing/Newswire/PR News to My MSNAdd Marketing/Newswire/PR News to My Yahoo!Add NewswireToday Marketing/Newswire/PR Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner

This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read More Articles From Dentsu / Company Profile



Read Marketing/Newswire/PR Most Recent Related Press Releases:

Leading Press Release Newswire and Market Research Report Distribution Service Network Celebrates 10 Year Anniversary
Dentsu Announces Acquisition of White Label - a Digital Performance Agency in Chile
Dentsu Announces Agreement to Acquire 100% Stake in Red Communication, a Media and Performance Agency in Norway
Dentsu Announces Agreement to Acquire 100% Stake in M8, a Digital Agency in the United States
Dentsu Announces Its Corporate Venture Capital Fund Dentsu Ventures Investment in FOLIO Co., Ltd
Dentsu Announces an Agreement to Acquire a Majority Stake in HelloWorld, a Promotion and Loyalty Solutions Provider in the United States
Dentsu Announces Agreement to Acquire 100% of DWA, a Global B-to-B Digital Marketing Agency in the United States
Dentsu Announces an Agreement to Acquire a 100% Stake in Swirl - A Digital Marketing Agency in the United States
Dentsu Announces Agreement to Acquire a 100% Stake in PT Valuklik - A Leading Digital Performance Marketing Company in Indonesia
Dentsu Announces an Agreement to Acquire a 78.8% Stake in Oxyma, an Omni-channel CRM Agency in the Netherlands

Reserve This Permanent SPACE

Your LOGO permanently HERE on PRTODAY - Newswire Distribution Service most visited Page start at $295 per month

 
Sponsored Links


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.

Visit  NAKIVO, Inc.





Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



 
  ©2014 PRTODAY — Limelon Advertising, Co.
Home | About PRTODAY | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report news market search pr firms pr agencies business reports newswire today distri- bution investor relation successful internet entrepreneur free newswire distribution prtoday freenewswiredistribution.com asianewstoday bizwiretoday newswire pr today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)